Similarly, Tsao et al.67 assessed the relationship between C1QB expression and overall survival rate for Her2-positive, luminal A, luminal B, and basal (triple-negative) breast cancer patients and found that the expression was associated with a better overall survival rate in patients with Her2-positive breast cancer than in those with other subtypes. The gene discussed is ERBB2; the disease is breast cancer.